Jan 09, 2017 13:02 pm UTC| Business
-- Expands Allergan’s Innovative GI Pipeline with ABI-M201 and ABI-M301, Preclinical Compounds Targeting Ulcerative Colitis and Crohn’s Disease, as well as Future Compounds for Irritable Bowel Syndrome -- DUBLIN,...
Jan 09, 2017 13:02 pm UTC| Business
2016 marks the third consecutive year of record passenger traffic10 airports also reached record passenger levels8 airports had double digit traffic growth in the yearThe Monterrey airport served 9.2 million passengers in...
Jan 09, 2017 13:02 pm UTC| Business
2016 marks the third consecutive year of record passenger traffic10 airports also reached record passenger levels8 airports had double digit traffic growth in the yearThe Monterrey airport served 9.2 million passengers in...
CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference
Jan 09, 2017 13:01 pm UTC| Business
SOUTH SAN FRANCISCO, Calif., Jan. 09, 2017 -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will present at the 35th...
Jan 09, 2017 13:01 pm UTC| Business
-- Biospecimens enriched with deep data insights for population analytics, prospective patient tracking and more -- CAMBRIDGE, Mass., Jan. 09, 2017 -- Novaseek Research LLC today announced that its Clinical Data...
Editas Medicine Reports on Recent Progress and 2017 Goals at J.P. Morgan Healthcare Conference
Jan 09, 2017 13:01 pm UTC| Business
- Company Achieves In Vivo Proof-of-Editing in the Retina of Non-Human Primates - - Unparalleled Genome Editing Platform Includes Cpf1 and Advanced Forms of Cas9 - CAMBRIDGE, Mass., Jan. 09, 2017 -- In a presentation...
Jan 09, 2017 13:01 pm UTC| Business
Two Phase 3 trials completed for Rekynda; co-primary endpoints met Will address underserved medical condition with significant untapped market potential Broadens AMAG’s presence in women’s health and leverages AMAG’s...